Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
Sushil Kumar, Ajeya Nandi, Snahlata Singh, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies
Vivek Kumar, Mohit Vashishta, Lin Kong, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 177
NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 151
Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance
Taniya Saha, Kiven Erique Lukong
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 77
Hallmarks of cancer stemness
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 60
Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers
Yuanfang Li, Baiwei Zhao, Juzheng Peng, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101042-101042
Open Access | Times Cited: 33
Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: Current status and future perspectives
Mohammad Azam Ansari, Muthu Thiruvengadam, Baskar Venkidasamy, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 678-696
Closed Access | Times Cited: 44
Signaling pathways in the regulation of cancer stem cells and associated targeted therapy
Manni Wang, Wu Min
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 44
From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy
Zhenfeng Shi, Lei Tian, Taotao Qiang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 9, pp. 6390-6418
Closed Access | Times Cited: 40
Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development
Tianshu Zhang, Huimin Zhou, Kexin Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112616-112616
Open Access | Times Cited: 33
Dll1-Mediated Notch Signaling Drives Tumor Cell Cross-talk with Cancer-Associated Fibroblasts to Promote Radioresistance in Breast Cancer
Ajeya Nandi, Rahul Debnath, Anupma Nayak, et al.
Cancer Research (2022) Vol. 82, Iss. 20, pp. 3718-3733
Open Access | Times Cited: 29
Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications
Alejandro Ordaz-Ramos, Olivia Tellez‐Jiménez, Karla Vázquez-Santillan
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 20
Preclinical and Clinical Trials of New Treatment Strategies Targeting Cancer Stem Cells in Subtypes of Breast Cancer
Natalia Landeros, Iván Castillo, Ramón Pérez-Castro
Cells (2023) Vol. 12, Iss. 5, pp. 720-720
Open Access | Times Cited: 16
NF-κB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges
Qing Guo, Yizi Jin, Mingxi Lin, et al.
Life Sciences (2024) Vol. 348, pp. 122684-122684
Closed Access | Times Cited: 7
Mammary Development and Breast Cancer: a Notch Perspective
Weizhen Chen, Wei Wei, Liya E. Yu, et al.
Journal of Mammary Gland Biology and Neoplasia (2021) Vol. 26, Iss. 3, pp. 309-320
Open Access | Times Cited: 34
Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications
Lei Wang, Jin Zeng, Rohan P. Master, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3287-3287
Open Access | Times Cited: 25
Ablation of p57+ Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
Takeru Oka, Tsunaki Higa, Osamu Sugahara, et al.
Cancer Research (2023) Vol. 83, Iss. 9, pp. 1393-1409
Open Access | Times Cited: 14
Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance
Mei Feng, Ramesh Kumar Santhanam, Huan Xing, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115991-115991
Closed Access | Times Cited: 14
ZEB1: Catalyst of immune escape during tumor metastasis
Jiahui Lü, Fei Fei, Chenxi Wu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113490-113490
Open Access | Times Cited: 21
Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs
Uttam Sharma, Hardeep Singh Tuli, Vivek Uttam, et al.
Pharmacological Research (2022) Vol. 186, pp. 106523-106523
Closed Access | Times Cited: 21
Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance
Mehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 1151-1167
Closed Access | Times Cited: 20
DNA Damage-driven Inflammatory Cytokines: Reprogramming of Tumor Immune Microenvironment and Application of Oncotherapy
Mengjie Wang, Xia Yu, Qinglei Gao
Current Medical Science (2024) Vol. 44, Iss. 2, pp. 261-272
Closed Access | Times Cited: 4
Current development of molecular classifications of gastric cancer based on omics (Review)
Yubo Ma, Zhengchen Jiang, Li-Bin Pan, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Open Access | Times Cited: 4
A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AML
Elahe Rahimian, Maryam Koochak, Sofia Traikov, et al.
Drug Resistance Updates (2025), pp. 101242-101242
Open Access
Syk/BLNK/NF-κB signaling promotes pancreatic injury induced by tacrolimus and potential protective effect from rapamycin
Xiao Chen, Ke Hu, Hao-Zhe Shi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116125-116125
Open Access | Times Cited: 3
Exploring the interplay between triple‐negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies
Zhuoling Zou, Tinglan Luo, Xinyuan Wang, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 8
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top